Collagen VI-Related Dystrophy

Collagen VI-related dystrophy is a group of rare genetic diseases that damage the muscles and the supporting tissues around them. In this condition, the body has changes (variants) in special genes called COL6A1, COL6A2, and COL6A3. These genes give the instructions to make a protein called type VI collagen. This collagen sits outside the muscle cells in a “support net” called the extracellular matrix. When collagen VI is missing or not working well, the net becomes weak. The muscles and connective tissue (skin, joints, tendons) are not supported properly, so they slowly become weak, stiff, or loose.

Collagen VI-related dystrophy is a rare group of inherited muscle diseases caused by changes (mutations) in collagen VI genes (COL6A1, COL6A2, COL6A3). Collagen VI is a structural protein that sits around muscle cells like a flexible net and helps keep them stable and healthy. When collagen VI does not work properly, muscle fibers are fragile and can be damaged easily, leading to weakness, joint stiffness (contractures), and problems with breathing over time [1].

Doctors usually describe three main clinical forms along a spectrum: Ullrich congenital muscular dystrophy (more severe, weakness and contractures from infancy, early loss of walking), an intermediate form, and Bethlem myopathy (milder, with later onset and slower progression). Even within the same family, people can be affected very differently, from needing a wheelchair in childhood to having only mild weakness in adult life [2].

Doctors now see collagen VI-related dystrophy as a spectrum of disease. At the mild end is Bethlem muscular dystrophy, in the middle are intermediate forms, and at the severe end is Ullrich congenital muscular dystrophy. All of them share certain features: muscle weakness, joint problems (loose joints and tight joints, called contractures), and sometimes changes in the skin. The age of onset, speed of worsening, and level of disability can be very different from person to person, even inside the same family.

Over time, many people with collagen VI-related dystrophy develop difficulty walking long distances, getting up from the floor, or climbing stairs. Some need wheelchairs. Because the muscles that help us breathe can also become weak, breathing problems and sleep-related breathing issues can appear, especially in the more severe or long-standing forms. This is why regular check-up of breathing and spine is a key part of care.

Other names

Collagen VI-related dystrophy has several other names in the medical literature. These names all refer to closely related conditions caused by problems in collagen VI:

1. Collagen VI-related myopathy – “Myopathy” means a disease that mainly affects muscles.

2. Collagen VI muscular dystrophy – Stresses that it is a type of muscular dystrophy caused by collagen VI problems.

3. Collagen VI myopathies – Used when talking about the whole group of conditions together.

4. Collagen VI-related muscular dystrophy – Another wording that means the same spectrum.

5. COL6-RDs (collagen VI-related dystrophies) – A short label used in research and reviews.

6. Bethlem muscular dystrophy / Bethlem myopathy – The classic mild end of the collagen VI spectrum.

7. Ullrich congenital muscular dystrophy (UCMD) – The classic severe end of the spectrum, starting in infancy.

8. Collagen VI-CMD (collagen VI congenital muscular dystrophy) – Often used when the disease starts in early childhood and fits congenital muscular dystrophy criteria.

These names can be confusing, but they all describe conditions linked to the same basic problem: abnormal collagen VI around muscle and connective tissue cells.

Types

Doctors describe several main types (or phenotypes) of collagen VI-related dystrophy. They share the same basic cause but differ in severity, age of onset, and speed of progression.

1. Bethlem muscular dystrophy (Bethlem myopathy)
   This is the milder form. Symptoms often start in late childhood or adulthood. People may have mild to moderate muscle weakness, especially in the hips and shoulders, and joint tightness in elbows, ankles, or fingers. Many can walk well into adult life, though they may have trouble running or climbing stairs. Some people only notice symptoms such as tight Achilles tendons, tiptoe walking, or difficulty squatting.

2. Ullrich congenital muscular dystrophy (UCMD)
   This is the severe form, usually seen from birth or early infancy. Babies may be “floppy” (low muscle tone), late to hold up the head, sit, or walk. They often have very loose joints in the hands and feet but stiff joints (contractures) in the elbows, knees, and hips. Many children with UCMD never walk independently or lose walking early. Progressive breathing weakness and spine curvature (scoliosis) are common, and respiratory support may be needed during sleep or later full time.

3. Intermediate collagen VI-related dystrophy
   Intermediate forms sit between Bethlem and UCMD. Children may walk independently but lose this ability later in childhood or teenage years. Contractures and joint looseness are present but not as extreme as in UCMD. Breathing problems may appear later than in classic UCMD. The same genes are involved, but the exact mutation and how it affects collagen VI assembly help decide the severity.

4. Myosclerosis myopathy (collagen VI-related)
   This rare form is mainly known for very tight muscles and severe contractures, making movement and joint stretching difficult. Muscle tissue becomes firm and fibrous (scar-like). It is also linked to COL6 gene mutations and sits in the collagen VI spectrum.

5. Limb-girdle–like collagen VI myopathy
   Some people with collagen VI mutations show mainly hip and shoulder (limb-girdle) weakness without clear congenital features. They may be diagnosed at first as having a limb-girdle muscular dystrophy, but genetic testing reveals COL6 changes. This shows how flexible and overlapping the collagen VI spectrum is.

Causes

In collagen VI-related dystrophy, the main cause is genetic. The disease is not caused by infection, trauma, or lifestyle. Instead, changes in certain genes lead to abnormal collagen VI protein and a weak support network around muscle and connective tissue cells. Below are 20 important causes or contributing factors that explain why the disease starts and how it becomes worse.

1. Pathogenic variants in COL6A1
   Harmful changes in the COL6A1 gene change the structure of one chain of collagen VI. This makes it hard for collagen VI molecules to build the normal network around muscle cells.

2. Pathogenic variants in COL6A2
   Changes in COL6A2 affect another collagen VI chain. Depending on where the change is and how it affects the protein, the disease may be mild (Bethlem) or severe (UCMD).

3. Pathogenic variants in COL6A3
   Mutations in COL6A3 damage the third collagen VI chain. Together with COL6A1 and COL6A2, these changes account for most known collagen VI-related dystrophies.

4. Dominant negative mutations
   In some people, one abnormal copy of a COL6 gene produces a “bad” collagen VI chain that mixes with the normal ones and spoils the whole collagen structure. This is called a dominant negative effect and often explains autosomal dominant forms like Bethlem myopathy and some UCMD cases.

5. Recessive loss-of-function mutations
   In other families, both copies of a COL6 gene are severely damaged, and very little or no collagen VI is made (loss of function). This is often linked to classic recessive UCMD, where symptoms are severe and start early in life.

6. Splice-site mutations
   Some variants occur at splice sites, the parts of the gene that tell the cell how to cut and join pieces of RNA. Wrong splicing can remove or add bits of the collagen VI chain, creating unstable or non-working protein.

7. De novo (new) mutations
   Many severe UCMD cases occur in children whose parents do not have the disease. The mutation appears “new” in the child (de novo). This explains why the condition can show up in a family with no prior history of muscular dystrophy.

8. Compound heterozygous mutations
   Some patients inherit two different harmful variants in the same COL6 gene, one from each parent (compound heterozygous). Together, these two variants reduce collagen VI function enough to cause disease.

9. Large deletions or duplications in COL6 genes
   Instead of a single small change, some people have larger missing or repeated segments in COL6 genes. These structural variants can remove important parts of the gene, leading to a non-functional collagen chain.

10. Abnormal collagen VI assembly and secretion
    Even when collagen VI is produced, abnormal chains may not assemble into a stable triple-helix or microfibril. Some mutant proteins are trapped inside the cell or secreted in a disorganized way, weakening the extracellular matrix around muscle fibers.

11. Defective extracellular matrix (ECM)
    The ECM provides a scaffold that holds muscle fibers in place and allows them to handle mechanical stress. In collagen VI-related dystrophy, this scaffold is patchy or detached from the cell surface, so muscle fibers are more easily damaged during normal movement.

12. Secondary muscle fiber degeneration
    Over time, repeated small injuries in unsupported muscle fibers lead to muscle fiber death and replacement with fat and fibrous tissue. This secondary degeneration is a key reason why weakness and contractures slowly get worse.

13. Joint laxity from weakened connective tissue
    Collagen VI is also important in tendons, ligaments, and skin. When these tissues are weak, joints can be overly loose. This joint laxity contributes to falls, instability, and later abnormal joint shapes.

14. Joint contractures from fibrosis and poor movement
    At the same time, some joints become too tight because muscle is replaced by stiff fibrous tissue and because it is difficult and painful to stretch weak muscles. These contractures are partly a result of the basic collagen VI defect and partly of reduced movement over time.

15. Spine deformity (scoliosis and kyphosis)
    Weak trunk muscles and an unstable ECM can lead to curvature of the spine. Once scoliosis develops, it can further worsen breathing by changing chest shape, and this adds to the functional impact of the original genetic problem.

16. Respiratory muscle weakness
    The diaphragm and intercostal muscles depend on good ECM support as well. As they weaken, breathing becomes shallow, especially at night. This can cause high carbon dioxide levels and fatigue, which further reduce activity and muscle strength.

17. Skin and scar changes
    Abnormal collagen VI can cause rough or thickened skin and unusual scars after minor injuries. These connective tissue problems may not “cause” the muscle disease but show that the same defect affects multiple tissues.

18. Modifier genes
    Other genes (outside COL6) may slightly improve or worsen how collagen VI mutations show in the body. They may alter muscle repair, fibrosis, or inflammation. This helps explain why two people with the same COL6 variant can have different severity.

19. Environmental and mechanical stress on muscles
    Normal daily activity puts strain on muscle fibers. In someone with weak ECM, even regular activity can cause small injuries. Over years, this mechanical stress adds to muscle damage and helps drive progression.

20. Delayed diagnosis and lack of early supportive care
    When the condition is not recognized early, contractures, scoliosis, and breathing problems may not be managed in time. This does not cause the genetic disease but can worsen the final level of disability, showing how important early recognition and care are.

Symptoms

Symptoms can vary widely, but certain features are common across the collagen VI spectrum. Below are 15 key symptoms, explained in simple language.

1. Muscle weakness in the hips and shoulders
   Many people first notice weakness in the muscles that lift the arms or move the legs at the hips. They may have trouble getting up from a low chair, climbing stairs, or lifting heavy objects. Over time, walking speed and endurance can fall.

2. Delayed motor milestones
   Babies with severe forms may be late to hold up their head, roll over, sit alone, crawl, or walk. Parents may notice that the baby feels “floppy” or cannot reach age-typical motor skills without extra support.

3. Low muscle tone (hypotonia)
   Muscle tone is the amount of tension in resting muscle. In collagen VI-related dystrophy, tone can be low, especially in infants and young children. The child may seem soft or “double-jointed” when you move their arms and legs.

4. Joint hyperlaxity (very loose joints)
   Some joints, especially in the fingers, wrists, and ankles, can bend more than normal. This joint laxity can look like great flexibility but actually reflects weak connective tissue and can lead to joint pain or instability.

5. Joint contractures (fixed tight joints)
   At the same time, other joints become stiff and difficult to straighten. Common contractures involve elbows, knees, ankles, and fingers. These fixed positions make walking, standing, and self-care tasks like dressing more difficult.

6. Tiptoe walking and tight Achilles tendons
   Tightness in the calf muscles and Achilles tendons can cause tiptoe walking. In milder forms like Bethlem myopathy, this may be one of the first signs in childhood or teenage years.

7. Difficulty getting up from the floor (positive Gowers’ sign)
   Children may need to “climb up” their legs with their hands when rising from the floor because the hip and thigh muscles are too weak. This classic pattern is called Gowers’ sign and is common in several muscular dystrophies, including collagen VI-related ones.

8. Spine curvature (scoliosis and kyphosis)
   Weak trunk muscles and uneven muscle pulling on the spine can cause the back to curve sideways (scoliosis) or round forward (kyphosis). These curves can make sitting, standing, and breathing more difficult if they become severe.

9. Breathing problems, especially during sleep
   As breathing muscles weaken, some people feel short of breath, have morning headaches, or feel very tired during the day. At night, shallow breathing can cause low oxygen and high carbon dioxide levels. Sleep studies often show sleep-disordered breathing and hypoventilation.

10. Frequent chest infections
    Weak cough and poor lung expansion make it hard to clear mucus from the airways. This can lead to repeated chest infections, which further weaken the lungs and increase the need for respiratory support.

11. Fatigue and reduced stamina
    Many people report feeling easily tired with physical activity. Even simple tasks, like walking short distances or doing chores, may require rest breaks. Fatigue may be worse in the presence of breathing problems or poor sleep.

12. Foot deformities (such as flat feet or high-arched feet)
    Abnormal muscle pulling and ligament weakness can change the shape of the feet over time. Some people develop flat feet or high arches, often with toe deformities, which may make walking and shoe fitting difficult.

13. Skin changes and abnormal scarring
    People with collagen VI-related disorders may have rough, thickened skin on hands and feet or “cigarette paper” scars that look thin and wrinkled. This reflects connective tissue involvement and can help doctors suspect the diagnosis.

14. Pain and stiffness
    Contractures, scoliosis, and abnormal posture can cause chronic muscle and joint pain. Stiffness on waking, discomfort after sitting long periods, or back pain are common complaints, especially in older children and adults.

15. Loss of walking ability over time (in some forms)
    In intermediate and severe forms, people who walked in childhood may slowly lose the ability to walk in adolescence or adulthood. This depends on the specific gene variant, degree of contractures, and quality of supportive care such as physiotherapy and orthopaedic interventions.

Diagnostic tests

Diagnosis of collagen VI-related dystrophy combines clinical examination, functional tests, laboratory and pathological studies, electrodiagnostic tests, and imaging. Below are 20 important tests, grouped by category but explained one by one in simple language.

1. General neuromuscular physical examination (Physical exam)
   The doctor looks at how the person sits, stands, and walks, checks posture, and inspects for muscle wasting and spine curvature. They gently move the arms and legs to feel joint range and see which joints are too loose or too tight. This first overview helps the doctor suspect a congenital muscular dystrophy such as a collagen VI-related disorder.

2. Joint range-of-motion assessment (Physical exam)
   Using a simple tool called a goniometer or by experienced visual estimation, the clinician measures how far each major joint can bend and straighten. Limited movement shows contractures, while extra movement shows hyperlaxity. The pattern of tight and loose joints is very characteristic in collagen VI-related dystrophy.

3. Manual muscle testing with MRC scale (Manual test)
   The doctor or physiotherapist tests each muscle group by asking the person to push or pull against resistance, grading strength from 0 (no movement) to 5 (normal). Typical findings are weakness in hip and shoulder muscles with relatively preserved finger strength, matching the known pattern for collagen VI-related conditions.

4. Gowers’ sign assessment (Manual test)
   The child is asked to rise from the floor without help. If they must roll onto their stomach, push up on their hands, and “climb” up their thighs, this is a positive Gowers’ sign. It shows weakness in the hip and thigh muscles and supports the diagnosis of a proximal myopathy such as collagen VI-related dystrophy.

5. Timed rise from floor or timed walk tests (Manual test)
   Simple timing tests, such as “time to stand from sitting” or “time to walk 10 meters,” help measure motor function. Repeating these tests over time allows doctors to see if the disease is stable, slowly worsening, or responding to supportive treatments like physiotherapy or orthoses.

6. Handgrip dynamometry (Manual test)
   A small device (dynamometer) measures how strongly a person can squeeze with their hand. In some collagen VI-related dystrophies, hand strength may be relatively preserved compared to hip and shoulder strength, which helps distinguish this condition from other muscular dystrophies.

7. Respiratory physical exam and cough assessment (Physical exam)
   The doctor watches chest movement, listens to breath sounds with a stethoscope, and checks how strong the cough is. Weak cough and shallow chest expansion suggest respiratory muscle weakness, prompting further lung tests and possibly early respiratory support.

8. Serum creatine kinase (CK) level (Lab test)
   CK is an enzyme that leaks from damaged muscle into the blood. In collagen VI-related dystrophy, CK can be normal or only mildly raised, which is helpful in distinguishing it from some other muscular dystrophies where CK is very high. This test is easy and often done early in the workup.

9. Routine blood and metabolic tests (Lab test)
   Blood tests such as full blood count, liver enzymes, thyroid tests, and metabolic panels help rule out other causes of muscle weakness (such as metabolic myopathies or endocrine disorders). While not specific for collagen VI-related dystrophy, they are important to build a full picture and exclude treatable alternatives.

10. Genetic sequencing of COL6A1, COL6A2, COL6A3 (Lab / pathological test)
    This is the key confirmatory test. Next-generation sequencing panels for neuromuscular disease or whole exome/genome sequencing can detect pathogenic variants in COL6 genes. Finding a disease-causing variant that fits the clinical picture makes the diagnosis certain and helps with genetic counseling for the family.

11. Deletion/duplication analysis of COL6 genes (Lab / pathological test)
    If standard sequencing is negative but suspicion remains high, special tests can look for larger deletions or duplications of DNA in COL6 genes. These structural variants may be missed by routine sequencing but can clearly disrupt gene function.

12. Muscle biopsy (Pathological test)
    A small piece of muscle, usually from the thigh or upper arm, is removed under local or general anesthesia. Under the microscope, the pathologist may see a dystrophic pattern with fiber size variation, fiber degeneration, and fibrosis, supporting a diagnosis of muscular dystrophy and guiding further specialized studies.

13. Immunohistochemistry for collagen VI on muscle (Pathological test)
    Special antibodies that attach to collagen VI are applied to the muscle biopsy. If collagen VI is missing or arranged abnormally around muscle fibers, the pattern strongly suggests a collagen VI-related dystrophy and helps focus genetic testing on COL6 genes.

14. Skin biopsy with collagen VI staining (Pathological test)
    Because collagen VI is abundant in skin, a small skin sample can also be used to study its pattern. Abnormal or reduced collagen VI around skin fibroblasts can be easier to detect than in muscle and provides another route to diagnosis, especially in young children or when muscle biopsy is difficult.

15. Electromyography (EMG) (Electrodiagnostic test)
    EMG uses thin needle electrodes in muscle to record electrical activity. In collagen VI-related dystrophy, EMG usually shows a “myopathic” pattern: small, brief motor unit potentials with early recruitment. This pattern supports the idea of muscle fiber disease rather than nerve disease.

16. Nerve conduction studies (NCS) (Electrodiagnostic test)
    Surface electrodes stimulate nerves and record responses. In collagen VI-related dystrophy, nerve conduction is usually normal, which helps exclude neuropathies. Normal NCS with myopathic EMG findings points toward a primary muscle disorder.

17. Overnight oximetry or polysomnography (sleep study) (Electrodiagnostic/physiologic test)
    Sleep studies measure oxygen levels, breathing patterns, heart rate, and sometimes brain waves during sleep. In collagen VI-related dystrophy, they can show hypoventilation (too little breathing), low oxygen, or sleep apnea, even when daytime symptoms are mild. This guides the start of non-invasive ventilation and other respiratory support.

18. Muscle MRI (Imaging test)
    MRI scans of thighs and calves can show characteristic patterns of muscle wasting and fat replacement in collagen VI-related conditions. Certain muscles are more affected than others, which helps distinguish this disorder from other muscular dystrophies and can even guide which muscle to biopsy.

19. Spine and joint X-rays (Imaging test)
    X-rays of the spine, hips, knees, and ankles show contractures, scoliosis, and joint deformities. This information helps orthopaedic and rehabilitation specialists plan treatments such as braces, stretching programs, or surgery to maintain sitting and standing posture.

20. Chest imaging and echocardiography (Imaging / functional tests)
    Chest X-ray or CT can show lung size and shape, as well as the effect of scoliosis on the rib cage. Echocardiography looks at heart structure and pumping. Although heart involvement is usually limited in collagen VI-related dystrophies, regular monitoring is recommended in neuromuscular diseases to detect any unexpected cardiac problems early.

Non-pharmacological treatments (therapies and other approaches)

Because there is no specific drug cure, supportive therapies are the heart of treatment in collagen VI-related dystrophy. These approaches aim to preserve movement, comfort, breathing, and independence as long as possible [4].

1. Regular physiotherapy and stretching
Physiotherapy uses gentle, regular stretching and movement exercises to keep joints flexible and reduce contractures. The purpose is to maintain the best possible range of motion in the hips, knees, ankles, elbows, and fingers, and to delay stiffness and deformities. The main mechanism is mechanical: slow stretches and positioning prevent shortening of muscles and tendons, which can otherwise worsen weakness and posture problems over time [5].

2. Respiratory physiotherapy and airway clearance
Respiratory therapists teach breathing exercises, assisted coughing, and use of mechanical cough-assist devices. The purpose is to clear mucus from the lungs, prevent infections, and support weak breathing muscles. The mechanism is again mechanical: positive pressure or manual techniques help move secretions out of the airways and improve ventilation, especially when the diaphragm is weak or scoliosis restricts chest movement [6].

3. Night-time non-invasive ventilation (BiPAP/NIV)
Many people with collagen VI-related dystrophy develop weak breathing muscles while still looking stable during the day. Night-time BiPAP (bilevel positive airway pressure) supports breathing during sleep. The purpose is to prevent low oxygen and high carbon dioxide at night, improve sleep quality, and protect the heart and lungs. The mechanism is that the machine provides gentle pressure through a mask, taking over some of the work of the respiratory muscles [7].

4. Orthopedic management with splints and braces
Orthopedic teams use ankle–foot orthoses, knee splints, wrist/hand splints, and spinal braces. The purpose is to support weak muscles, prevent or reduce contractures, improve standing posture, and delay scoliosis. Mechanistically, braces hold joints in more neutral positions and distribute pressure more evenly, lowering the risk of fixed deformities and pain, even though they do not make muscles stronger [8].

5. Seating systems and standing frames
Custom wheelchairs with good support for the trunk, pelvis, and head, plus standing frames, help with posture and bone health. The purpose is to make sitting and daily activities safer and more comfortable, reduce pressure sores, and support social participation. The mechanism is biomechanical: proper alignment reduces strain on joints and spine and improves breathing and swallowing by opening the chest and abdomen [9].

6. Occupational therapy and adaptive equipment
Occupational therapists adapt the home and school environment and recommend aids such as adapted cutlery, writing supports, computer access tools, and bathroom aids. The purpose is to maintain independence in daily living (eating, dressing, bathing, communication). The mechanism is practical and environmental: instead of changing the body, these tools change the tasks and surroundings so that a person can function well despite weakness or contractures [10].

7. Exercise within safe limits (swimming, walking, cycling)
Light to moderate, low-impact exercise such as swimming, gentle cycling, and walking (if possible) is encouraged. The purpose is to maintain cardiovascular fitness, prevent deconditioning, and support emotional well-being. The mechanism is that regular, careful use of muscles helps maintain strength without over-straining fragile fibers; therapists guide patients to avoid high-impact or eccentric exercises that can cause damage [11].

8. Nutritional support and swallowing therapy
Dietitians and speech-and-language therapists monitor weight, chewing, and swallowing. The purpose is to prevent malnutrition, aspiration, and constipation. The mechanism is a mix of diet changes (appropriate calories, textures, and fluids) and swallowing strategies or exercises to protect the airway and make eating safer, sometimes combined with positioning or thickened fluids when needed [12].

9. Psychological support and family counseling
Living with a chronic muscle disease affects mood, self-image, school or work, and family dynamics. Psychologists or counselors help with coping strategies, anxiety, low mood, and family stress. The mechanism is emotional and cognitive: talking therapies, peer support groups, and educational support can lower psychological burden and improve adherence to physical and medical treatments [13].

10. Genetic counseling for family planning
Genetic counseling provides information about inheritance patterns, recurrence risks, and testing options for relatives. The purpose is informed decision-making and early diagnosis in family members. The mechanism is educational: understanding autosomal dominant or recessive inheritance and carrier status helps families plan pregnancies, newborn screening, and early surveillance for symptoms [14].

11. Careful peri-operative planning for anesthesia
People with collagen VI-related dystrophy may need surgeries such as tendon release or spinal fusion. Anesthesia teams must assess airway, breathing, and cardiac status in advance. The purpose is to reduce the risk of respiratory failure and airway difficulties during and after surgery. The mechanism is anticipatory planning: selecting appropriate drugs, ventilation strategies, and postoperative intensive care based on the patient’s muscle and lung status [15].

12. School and vocational support
Educational adjustments, assistive technology, and flexible schedules help children and adults continue school or work. The purpose is to support social participation and long-term independence. The mechanism is environmental and social: removing physical and organizational barriers allows the person to use their remaining abilities effectively and stay integrated in community life [16].

---

Drug treatments

There is no drug approved specifically to cure collagen VI-related dystrophy, but several FDA-approved medicines are commonly used to treat symptoms such as spasticity, pain, infections, reflux, and sleep problems. Below are examples; doses and exact choices must be individualized and taken only under medical supervision. Drug label information for many of these medicines is available in the US FDA database [17].

1. Baclofen for muscle stiffness or spasms
Baclofen is a gamma-aminobutyric acid (GABA-B) agonist used to treat spasticity in conditions such as multiple sclerosis and spinal cord disease. Some patients with dystrophies who develop increased tone or spasms may receive baclofen to improve comfort and mobility. Typical oral doses are divided several times daily and are increased slowly by a doctor to balance benefit and side effects such as drowsiness and weakness. Abrupt withdrawal can cause serious reactions, so the medicine must never be stopped suddenly [18].

2. Prednisone / prednisolone for inflammatory complications
Prednisone and prednisolone are glucocorticoids approved for many inflammatory and allergic conditions. In collagen VI-related dystrophy, they are not routine chronic treatment, but short courses may be used for asthma-like airway inflammation, autoimmune complications, or after major surgery to reduce swelling, always under specialist guidance. Doses are based on weight and indication and are tapered gradually to avoid adrenal suppression. Side effects include weight gain, high blood sugar, mood changes, infection risk, and bone loss [19].

3. Short-acting bronchodilators (for wheeze or asthma-like symptoms)
Inhaled beta-2 agonists such as albuterol (salbutamol) are widely used to relax airway smooth muscle and relieve wheeze and shortness of breath. They do not treat muscle weakness but can help if a person with collagen VI-related dystrophy also has reactive airway disease. Metered-dose inhalers or nebulizers are used, and dosing frequency is set by a doctor. Common side effects are tremor, fast heartbeat, and agitation [20].

4. Inhaled corticosteroids (for chronic airway inflammation)
Inhaled steroids such as budesonide or fluticasone reduce airway inflammation in asthma and chronic reactive airway disease. In a person with weak respiratory muscles, good control of airway inflammation is important to lower infection risk and breathing effort. Doses are usually given once or twice daily via inhaler and spacer. Side effects can include oral thrush and hoarse voice, which can be reduced by rinsing the mouth after use [21].

5. Antibiotics for respiratory infections
Because weak breathing muscles and scoliosis reduce lung clearance, chest infections can become severe. Oral or intravenous antibiotics (such as amoxicillin or macrolides) are prescribed promptly when bacterial pneumonia is suspected. The purpose is to quickly control infection, protect lung function, and prevent respiratory failure. Choice, dose, and duration depend on age, kidney function, and local resistance patterns, and must follow national guidelines [22].

6. Analgesics (paracetamol and NSAIDs) for pain
Pain can result from contractures, scoliosis, or post-operative recovery. Paracetamol (acetaminophen) and non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are commonly used under medical supervision. They act by blocking pain and inflammation pathways in the brain and body. Doses are weight-based, with strict maximum daily limits to avoid liver or kidney toxicity. Side effects may include stomach upset or, rarely, kidney problems with long-term NSAID use [23].

7. Opioid medicines for severe pain (short-term, specialist use)
In cases of severe post-surgical pain (for example after spinal fusion), short courses of opioids such as morphine may be used in hospital settings. They act on opioid receptors to reduce the perception of pain but also depress breathing and can cause constipation and drowsiness. Because respiratory muscles are already weak in collagen VI-related dystrophy, opioids must be used carefully with close monitoring and usually together with non-drug pain strategies [24].

8. Medicines for gastro-oesophageal reflux
Weak trunk muscles, scoliosis, and non-invasive ventilation masks can worsen reflux. Proton pump inhibitors (PPIs) or H2-blockers reduce stomach acid production and protect the oesophagus from irritation. Typical dosing is once or twice daily before meals, as prescribed by a doctor. Side effects can include headache, diarrhoea, or altered mineral absorption with very long-term use, so the indication should be reviewed regularly [25].

9. Laxatives and stool softeners
Immobility, low fluid intake, and some medicines (especially opioids) commonly lead to constipation. Osmotic laxatives (like polyethylene glycol) and stool softeners help keep stool moist and easier to pass. They work by drawing water into the bowel or altering stool consistency. Adequate fibre, fluid, and physical activity (if possible) should be tried first, and laxatives should be guided by a doctor or dietitian [26].

10. Bone health medicines in selected cases
Chronic immobility and corticosteroid use can cause osteoporosis. In some adolescents or adults, doctors may prescribe calcium, vitamin D, and sometimes bisphosphonates to improve bone density. These treatments work by improving bone mineralisation or slowing bone resorption. They require careful monitoring of kidney function, calcium levels, and dental health, and are usually managed by endocrinology or metabolic bone specialists [27].

(In practice, most patients will use only a few of these medicines, chosen specifically for their situation.)

---

Dietary molecular supplements

Evidence for supplements in collagen VI-related dystrophy is limited, and no supplement has been proven to cure or clearly slow the disease. Some are used to support general muscle and bone health. They should always be discussed with a doctor or dietitian.

1. Vitamin D
Vitamin D supports calcium absorption and bone health, which is vital in people with limited mobility and steroid exposure. Supplementation helps prevent rickets in children and osteoporosis in adults. The mechanism is hormonal: vitamin D acts on the gut, kidneys, and bones to balance calcium and phosphate. Dose depends on age, baseline level, and sun exposure and must be checked with blood tests to avoid deficiency or toxicity [28].

2. Calcium supplements
When dietary intake is low or bone density is poor, calcium supplements may be advised together with vitamin D. The purpose is to provide enough building material for bones and teeth. Calcium works structurally in bone and also in muscle and nerve function. Doses are usually divided with meals to improve absorption. Too much calcium can cause kidney stones or interact with other medicines, so professional guidance is essential [29].

3. Omega-3 fatty acids (fish oil)
Omega-3 fatty acids have mild anti-inflammatory effects and may support heart and brain health. In neuromuscular diseases, they are sometimes used as a general wellness supplement, although direct evidence in collagen VI-related dystrophy is lacking. They act by modifying cell membrane composition and inflammatory signalling pathways. Typical daily doses are based on total EPA/DHA content; side effects can include fishy after-taste and, rarely, increased bleeding tendency at high doses [30].

4. Coenzyme Q10
Coenzyme Q10 is involved in mitochondrial energy production. Because mitochondrial dysfunction has been observed in collagen VI-related myopathies, some clinicians consider CoQ10 as an experimental supportive supplement, although robust clinical proof is still missing. It acts in the electron transport chain within mitochondria, helping to generate ATP. Dosing varies; side effects are usually mild, such as stomach upset. Any use should be part of a supervised care plan [31].

5. Creatine monohydrate
Creatine helps muscles rapidly recycle energy during short bursts of activity. In some neuromuscular conditions, creatine has been studied to see whether it can modestly improve strength or endurance. The mechanism is biochemical: creatine phosphate buffers ATP levels in muscle. Doses and safety must be assessed by a doctor, especially in children and in people with kidney problems, because long-term effects are still being evaluated [32].

(Other common supplements such as multivitamins, protein powders, or probiotics may be used for general health but have no specific evidence for collagen VI-related dystrophy.)

---

Immunity-boosting, regenerative, and stem-cell-related approaches

At present, there are no approved stem-cell drugs or gene therapies specifically for collagen VI-related dystrophy. Experimental research is exploring ways to correct collagen VI defects or protect mitochondria, but these are mainly in animal models or very early studies.

1. Vaccinations as immune protection
The strongest “immune booster” for people with neuromuscular disorders is staying up to date with standard vaccines, especially influenza and pneumococcal vaccines. These vaccines work by training the immune system to recognize germs before they cause severe infection. This is crucial because chest infections can be particularly dangerous when breathing muscles are weak [33].

2. General immune support through lifestyle
Adequate sleep, balanced diet, treatment of reflux, and good mouth care all indirectly support immune function by reducing chronic stress and inflammation. These are not “drugs” but are essential for lowering infection risk. Mechanistically, they help the body maintain normal hormone balance, microbiome health, and barrier function in the gut and airways.

3. Experimental mitochondrial-targeted therapies
Research has shown mitochondrial dysfunction in collagen VI-deficient muscle fibers. Some experimental drugs aim to stabilise mitochondria or reduce abnormal opening of the mitochondrial permeability transition pore, similar to the effects of cyclosporine-A–like agents in animal models. These strategies are not yet standard care, doses for humans are not established for this indication, and they should only be used within formal clinical trials [34].

4. Future gene and cell-based therapies
Several research groups are exploring gene editing, viral gene replacement, or cell-based therapies for collagen VI defects, but these approaches are at an early stage. The idea is to restore normal collagen VI production or supply healthy supporting cells to muscle. For now, there are no approved commercial products, and any participation should be within regulated, ethics-approved clinical trials with close safety monitoring.

---

Surgical treatments

Surgery is not used to “cure” collagen VI-related dystrophy but to correct or reduce complications like severe contractures, foot deformities, and scoliosis.

1. Tendon-lengthening surgery (for Achilles or hamstrings)
When contractures of the Achilles tendons or hamstrings severely limit walking, standing, or sitting, surgeons may lengthen these tendons. The purpose is to improve foot position or knee extension, making bracing, standing, and transferring easier. The mechanism is mechanical: lengthened tendons allow more range of motion, though they do not increase muscle strength and may need intensive physiotherapy afterwards [35].

2. Upper-limb contracture release
In some patients, severe elbow or wrist contractures interfere with feeding, hygiene, or wheelchair control. Surgical release of tight soft tissues can increase range of motion. The main aim is functional independence (for example, reaching the mouth or joystick). Risks include scarring and recurrence, so surgery is usually timed carefully and combined with splinting and physiotherapy [36].

3. Spinal fusion for scoliosis
Progressive scoliosis is common and can worsen breathing and sitting balance. Spinal fusion stabilises the spine by placing rods and bone grafts to hold it in a straighter position. The purpose is to improve posture, sitting comfort, and lung mechanics. Because anaesthesia and postoperative care are complex in neuromuscular patients, surgery is done only in specialised centres with detailed respiratory and cardiac planning [37].

4. Gastrostomy tube insertion
If swallowing becomes unsafe or oral intake is not enough to maintain weight, a gastrostomy tube (PEG or button) may be placed directly into the stomach. This allows safe delivery of nutrition, fluids, and medicines. The mechanism is bypassing the mouth and oesophagus, reducing aspiration risk and supporting growth and immune health. Families are taught how to care for the tube at home [38].

5. Airway procedures (rare, for severe respiratory failure)
In very severe cases with chronic respiratory failure and poor tolerance of mask ventilation, some patients may need a tracheostomy with long-term invasive ventilation. The goal is stable gas exchange and easier airway clearance. Because it changes breathing, speech, and infection risk, tracheostomy is considered only after detailed discussions with the family and multidisciplinary team [39].

---

Prevention and daily self-care strategies

There is no way to fully prevent collagen VI-related dystrophy because it is genetic, but many complications can be delayed or reduced.

1. Early diagnosis and enrolment in a neuromuscular clinic help start physiotherapy, respiratory monitoring, and orthopaedic care before serious problems develop [40].

2. Keeping vaccinations up to date (especially flu and pneumococcal shots) reduces the risk of severe chest infections in people with weak respiratory muscles.

3. Prompt treatment of respiratory infections with medical review, antibiotics when needed, and increased airway clearance helps prevent hospitalisation and long-term lung damage.

4. Daily stretching and proper positioning in bed, wheelchair, and standing frame slows joint contractures and postural deformities.

5. Safe, gentle physical activity avoids both complete inactivity and over-strenuous exercise that can damage fragile muscle fibres.

6. Healthy body weight (neither under- nor over-weight) reduces stress on joints and lungs and lowers surgical and anaesthesia risks.

7. Bone health measures (vitamin D, calcium, safe sun exposure, and, when indicated, bone medicines) help prevent fractures.

8. Regular scoliosis and contracture checks allow early bracing or surgery at the most favourable time.

9. Careful peri-operative planning for any surgery or anaesthesia reduces complications such as respiratory failure and difficult airway.

10. Genetic counselling for families can help parents understand recurrence risk and discuss options for future pregnancies.

---

When to see a doctor

You should see a neuromuscular or general doctor regularly, even when things seem stable, to check breathing, spine, joints, and nutrition. In addition, urgent medical review is important if:

• Breathing becomes more difficult, especially during sleep (frequent awakenings, morning headaches, nightmares, or daytime sleepiness).

• There are repeated chest infections, persistent cough, or wheeze.

• New or rapidly worsening contractures, scoliosis, or loss of previously gained motor skills appear.

• Swallowing becomes hard, with coughing or choking on food or drinks, unexplained weight loss, or frequent chest infections from aspiration.

• Severe pain, especially back pain or joint pain, limits movement or sleep.

• Any planned surgery or general anaesthetic is being considered; the anesthetist needs detailed information about the muscle condition.

Early review allows the team to adjust physiotherapy, braces, ventilation, nutrition, and medicines before problems become emergencies.

---

What to eat and what to avoid

A balanced, age-appropriate diet is essential in collagen VI-related dystrophy. People with limited movement need enough nutrients for growth, bone health, and immune function, but not so many calories that weight gain makes movement and breathing harder.

• Foods to prioritise:

  • Lean protein sources (fish, eggs, poultry, beans, lentils, dairy) to support muscle and immune health.

  • Fruits and vegetables of many colours, which provide vitamins, minerals, antioxidants, and fibre.

  • Whole grains (brown rice, whole-wheat bread, oats) for steady energy and bowel regularity.

  • Healthy fats (olive oil, nuts, seeds, avocado, oily fish) for calories and anti-inflammatory benefits.

• Foods and habits to limit:

  • Very sugary drinks and snacks that add calories without nutrients and promote weight gain.

  • Highly processed foods high in salt and saturated fat, which can affect heart and overall health.

  • Very hard, dry, or crumbly foods if swallowing is difficult; softer textures and thickened fluids may be safer when recommended by a speech therapist.

  • Large meals late at night, especially when reflux is present; smaller, earlier meals may reduce discomfort and aspiration risk.

Dietitians can individualise plans, especially when gastrostomy feeding or special formulas are needed.

---

Frequently asked questions

1. Is collagen VI-related dystrophy the same as Duchenne muscular dystrophy?
No. Both are muscular dystrophies, but they involve different genes and proteins and have different patterns of weakness, progression, and heart involvement. Collagen VI-related dystrophy mainly affects the connective tissue around muscle fibres and often causes early contractures and breathing problems, while Duchenne is due to dystrophin deficiency and usually has more pronounced heart and skeletal muscle involvement [41].

2. Can people with collagen VI-related dystrophy walk?
Some people, especially those with Bethlem myopathy, walk into adulthood, sometimes with support, while others with Ullrich congenital muscular dystrophy may never walk independently or may lose walking ability in childhood. Early physiotherapy, bracing, and safe exercise can help maintain mobility as long as possible, but the underlying genetic problem remains [42].

3. Does this disease affect the heart?
Heart involvement is less common and generally milder than in some other muscular dystrophies, but cardiac assessment is still recommended because the chest wall and breathing problems can indirectly strain the heart. Routine cardiology follow-up is part of many care guidelines for congenital muscular dystrophies [43].

4. What is life expectancy?
Life expectancy varies widely and depends on the clinical form and quality of care. With modern respiratory support, careful orthopaedic management, and prevention of infections, many children with more severe forms are living longer than in the past, while those with milder Bethlem myopathy may have near-normal life expectancy [44].

5. Can pregnancy be safe for someone with collagen VI-related dystrophy?
Some women with milder forms have had successful pregnancies, but pregnancy increases strain on breathing, heart, and spine. Pre-pregnancy counselling with neuromuscular specialists, obstetricians, and anesthetists is essential, and monitoring during pregnancy and delivery must be more intensive than usual. Decisions are highly individual.

6. Will my children definitely have the disease?
Not always. In autosomal dominant forms, each child has a 50% chance of inheriting the faulty gene; in recessive forms, the risk is 25% when both parents are carriers. Genetic testing and counselling can clarify the pattern in each family and discuss options such as prenatal or preimplantation diagnosis [45].

7. Are there clinical trials I can join?
Clinical trials for collagen VI-related dystrophy are limited but slowly increasing, especially those exploring mitochondrial-targeted therapies, exercise interventions, and natural history. Patient organisations and neuromuscular centres often keep lists of active studies. Participation is voluntary and should include a clear explanation of potential risks and benefits.

8. Can traditional or herbal medicines cure this disease?
No herbal or traditional remedy has been proven to cure collagen VI-related dystrophy. Some herbal products may interact with prescription medicines or cause side effects. Always tell your medical team about any supplements or remedies you are considering so they can check safety and interactions.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: February 09, 2025.